120 related articles for article (PubMed ID: 36725401)
21. A retrospective cohort study of metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy, with an exploratory analysis of changing serum carcinoembryonic antigen levels.
Ng SL; Burns WI; Snyder RD; Newnham GM; McLachlan SA; Liew D; Dowling AJ
Asia Pac J Clin Oncol; 2012 Jun; 8(2):172-9. PubMed ID: 22524576
[TBL] [Abstract][Full Text] [Related]
22. The prognostic role of baseline CEA and CA 19-9 values and their time-dependent variations in advanced colorectal cancer patients submitted to first-line therapy.
Tampellini M; Ottone A; Alabiso I; Baratelli C; Forti L; Berruti A; Aroasio E; Scagliotti GV
Tumour Biol; 2015 Mar; 36(3):1519-27. PubMed ID: 25374062
[TBL] [Abstract][Full Text] [Related]
23. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
24. Accessing new prognostic significance of preoperative carcinoembryonic antigen in colorectal cancer receiving tumor resection: More than positive and negative.
Cai Z; Xiao J; He X; Ke J; Zou Y; Chen Y; Wu X; Li X; Wang L; Wang J; Lan P; Wu X
Cancer Biomark; 2017; 19(2):161-168. PubMed ID: 28128739
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of carcinoembryonic antigen (CEA) density as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases.
Huo YR; Glenn D; Liauw W; Power M; Zhao J; Morris DL
Eur Radiol; 2017 Jan; 27(1):128-137. PubMed ID: 27165139
[TBL] [Abstract][Full Text] [Related]
26. Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal Cancer.
Chidimatsu H; Tsunedomi R; Nakagami Y; Xu M; Nakajima M; Nakashima-Nakasuga C; Tomochika S; Yoshida S; Suzuki N; Watanabe Y; Matsui H; Shindo Y; Tokumitsu Y; Iida M; Takeda S; Ioka T; Ueno T; Tanabe T; Hoshii Y; Hazama S; Nagano H
Anticancer Res; 2023 Jan; 43(1):105-114. PubMed ID: 36585204
[TBL] [Abstract][Full Text] [Related]
27. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
[TBL] [Abstract][Full Text] [Related]
28. CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC).
Sefrioui D; Beaussire L; Gillibert A; Blanchard F; Toure E; Bazille C; Perdrix A; Ziegler F; Gangloff A; Hassine M; Elie C; Bignon AL; Parzy A; Gomez P; Thill C; Clatot F; Sabourin JC; Frebourg T; Benichou J; Bouhier-Leporrier K; Gallais MP; Sarafan-Vasseur N; Michel P; Di Fiore F
Br J Cancer; 2021 Aug; 125(5):725-733. PubMed ID: 34112948
[TBL] [Abstract][Full Text] [Related]
29. CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial).
Michl M; Stintzing S; Fischer von Weikersthal L; Decker T; Kiani A; Vehling-Kaiser U; Al-Batran SE; Heintges T; Lerchenmueller C; Kahl C; Seipelt G; Kullmann F; Stauch M; Scheithauer W; Hielscher J; Scholz M; Mueller S; Lerch MM; Modest DP; Kirchner T; Jung A; Heinemann V;
Ann Oncol; 2016 Aug; 27(8):1565-72. PubMed ID: 27234640
[TBL] [Abstract][Full Text] [Related]
30. Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study.
Li C; Zhang D; Pang X; Pu H; Lei M; Fan B; Lv J; You D; Li Z; Zhang T
EBioMedicine; 2021 Dec; 74():103706. PubMed ID: 34801967
[TBL] [Abstract][Full Text] [Related]
31. Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer.
Arrieta O; Varela-Santoyo E; Cardona AF; Sánchez-Reyes R; Lara-Mejía L; Bassarmal SS; Valle-Bautista D; Corrales-Rodríguez L; Motola-Kuba D; Cabrera-Miranda L; Martín C
Clin Lung Cancer; 2021 Nov; 22(6):510-522. PubMed ID: 33947631
[TBL] [Abstract][Full Text] [Related]
32. Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy.
Jürgensmeier JM; Schmoll HJ; Robertson JD; Brooks L; Taboada M; Morgan SR; Wilson D; Hoff PM
Br J Cancer; 2013 Apr; 108(6):1316-23. PubMed ID: 23449351
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of carbohydrate antigen125 and carcino embryonic antigen expression in patients with colorectal carcinoma and its guiding significance for chemotherapy.
Mao J; Du P; Yang HT; Hu H; Wang SY; Wu X; Cheng ZB
Medicine (Baltimore); 2020 Apr; 99(14):e19420. PubMed ID: 32243362
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy-induced carcinoembryonic antigen surge in patients with metastatic colorectal cancer.
Ailawadhi S; Sunga A; Rajput A; Yang GY; Smith J; Fakih M
Oncology; 2006; 70(1):49-53. PubMed ID: 16446549
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab.
Nissen NI; Kehlet S; Boisen MK; Liljefors M; Jensen C; Johansen AZ; Johansen JS; Erler JT; Karsdal M; Mortensen JH; Høye A; Willumsen N
Sci Rep; 2021 Jan; 11(1):865. PubMed ID: 33441622
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of predictive markers for patients with advanced colorectal cancer.
Byström P; Berglund Å; Nygren P; Wernroth L; Johansson B; Larsson A; Glimelius B
Acta Oncol; 2012 Sep; 51(7):849-59. PubMed ID: 22974092
[TBL] [Abstract][Full Text] [Related]
37. Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome.
Thomsen M; Skovlund E; Sorbye H; Bolstad N; Nustad KJ; Glimelius B; Pfeiffer P; Kure EH; Johansen JS; Tveit KM; Christoffersen T; Guren TK
Br J Cancer; 2018 Jun; 118(12):1609-1616. PubMed ID: 29872151
[TBL] [Abstract][Full Text] [Related]
38. Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas.
Boonpipattanapong T; Chewatanakornkul S
J Clin Gastroenterol; 2006 Aug; 40(7):592-5. PubMed ID: 16917399
[TBL] [Abstract][Full Text] [Related]
39. Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer.
Osumi H; Shinozaki E; Ooki A; Shimozaki K; Kamiimabeppu D; Nakayama I; Wakatsuki T; Ogura M; Takahari D; Chin K; Yamaguchi K
Cancer Med; 2021 Dec; 10(24):8820-8828. PubMed ID: 34821068
[TBL] [Abstract][Full Text] [Related]
40. The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy.
Strimpakos AS; Cunningham D; Mikropoulos C; Petkar I; Barbachano Y; Chau I
Ann Oncol; 2010 May; 21(5):1013-9. PubMed ID: 19861580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
